E Jacky

1.8k citations

25 papers · 1.3k indexed · h-index 15

Impact in

Hematology top 1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in ⓘ

Hematology 10
- Acute Myeloid Leukemia Research 8
- Hematopoietic Stem Cell Transplantation 4
- Multiple Myeloma Research and Treatments 3
Genetics 3
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3

Co-authors: Bob Löwenberg (4 shared papers)Leo F. Verdonck (4 shared papers)Peter C. Huijgens (3 shared papers)Wim L.J. van Putten (3 shared papers)Edo Vellenga (3 shared papers)Martin F. Fey (5 shared papers)Marc Boogaerts (2 shared papers)Georgine E. de Greef (2 shared papers)
Journals: Annals of Oncology (4 papers)British Journal of Haematology (3 papers)Blood (3 papers)Journal of Clinical Oncology (2 papers)Oncology (2 papers)
Partner nations: Switzerland Netherlands Belgium

In The Last Decade

E Jacky

25 papers receiving 1.3k citations

Peers

Countries citing papers authored by E Jacky

Since Specialization

Citations

This map shows the geographic impact of E Jacky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Jacky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Jacky more than expected).

Fields of papers citing papers by E Jacky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Jacky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Jacky. The network helps show where E Jacky may publish in the future.

Co-authors

The 25 scholars most cited alongside E Jacky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E Jacky Line = papers co-authored together E Jacky links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Prognostic Index for Adult Patients With Acute Myeloid Leukemia in First Relapse Journal of Clinical Oncology ·Dimitri Breems, Wim L.J. van Putten, Peter C. Huijgens, Gert J. Ossenkoppele, Gregor Verhoef, Leo F. Verdonck, Edo Vellenga, Georgine E. de Greef, E Jacky, J. van der Lelie, Marc Boogaerts, Bob Löwenberg	2005	355
2	Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom? Blood ·Jan J. Cornelissen, Wim L.J. van Putten, Leo F. Verdonck, Matthias Theobald, E Jacky, Simon Daenen, Marinus van Marwijk Kooy, Pierre W. Wijermans, Harry C. Schouten, Peter C. Huijgens, Hans van der Lelie, Martin F. Fey, Augustin Ferrant, Johan Maertens, Aloïs Gratwohl, Bob Löwenberg	2007	345
3	Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies. Journal of Clinical Oncology ·Rolf A. Stahel, L.M. Jost, Thomas Cerny, Gabriella Pichert, Hanspeter Honegger, A Tobler, E Jacky, Martin F. Fey, E Platzer	1994	73
4	Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine Blood ·Thomas Pabst, Edo Vellenga, Wim van Putten, Harry C. Schouten, Carlos Graux, Marie‐Christiane Vekemans, Bart J. Biemond, Peter Sonneveld, Jakob Passweg, Leo F. Verdonck, Marie-Cecile Legdeur, Matthias Theobald, E Jacky, Mario Bargetzi, Johan Maertens, Gert J. Ossenkoppele, Bob Löwenberg	2012	65
5	Rituximab–EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study Annals of Oncology ·Monika Jermann, L.M. Jost, Ch. Taverna, E Jacky, Hanspeter Honegger, Daniel Betticher, F Egli, Th. Kroner, Rolf A. Stahel	2004	64
6	Increased urinary excretion of carnitine in patients treated with cisplatin European Journal of Clinical Pharmacology ·Wolfgang Heuberger, Simona Berardi, E Jacky, Pascaline Pey, Stephan Krähenbühl	1998	56
7	Sweet's syndrome involoving the musculoskeletal system during treatment of promyelocytic leukemia with all-trans retinoic acid. PubMed ·Emanuel Christ, A. Linka, E Jacky, Rudolf Speich, Borut Marinček, A.E. Schaffner	1996	55
8	Criteria for defining a complete remission in acute myeloid leukaemia revisited. An analysis of patients treated in HOVON‐SAKK co‐operative group studies British Journal of Haematology ·Georgine E. de Greef, Wim L.J. van Putten, Marc Boogaerts, Peter C. Huijgens, Leo F. Verdonck, Edo Vellenga, Matthias Theobald, E Jacky, Bob Löwenberg, (unknown)	2004	44
9	Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma Annals of Oncology ·R. Morant, J. Bernhard, Rudolf Maibach, Markus Borner, Martin F. Fey, Beat Thürlimann, E Jacky, Felix Trinkler, Jean Bauer, Gilbert B. Zulian, Silvia Hanselmann, Christoph Hürny, F. Hering	2000	38
10	Hepatic Lesions of Chronic Disseminated Candidiasis May Become Invisible During Neutropenia Blood ·Bernhard C. Pestalozzi, Gabriël P. Krestin, Urs Schanz, E Jacky, J Gmür	1997	33
11	Systematic screening at diagnosis of −5/del(5)(q31), −7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics Cancer Genetics and Cytogenetics ·Valérie Beyer, Chantal Castagné, Dominique Mühlematter, V. Parlier, J Gmür, U Hess, Tibor Kovacsovics, Sandrine Meyer‐Monard, André Tichelli, Andreas Tobler, E Jacky, Urs Schanz, Mario Bargetzi, Anne Hagemeijer, Théo de Witte, Guy van Melle, Martine Jotterand	2004	31
12	Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt’s lymphomas in adult patients Annals of Oncology ·L.M. Jost, E Jacky, Corina Dommann‐Scherrer, Hanspeter Honegger, Robert Maurer, C. Sauter, Rolf A. Stahel	1995	29
13	Post-remission therapy of adult acute myeloid leukaemia: One cycle of high-dose versus standard-dose cytarabine Annals of Oncology ·M. Fopp, Martin F. Fey, M. Bacchi, F. Cavalli, J. Gmuer, E Jacky, L. Schmid, André Tichelli, A Tobler, L Tschopp, V von Fliedner, Aloïs Gratwohl	1997	28
14	Vinorelbine in androgen-independent metastatic prostatic carcinoma—a phase II study European Journal of Cancer ·R. Morant, S.‐F. Hsu Schmitz, J. Bernhard, Beat Thürlimann, Markus Borner, Martin Wernli, F Egli, Pascal Forrer, A Streit, E Jacky, Silvia Hanselmann, Jean Bauer, F. Hering, Hans‐Peter Schmid	2002	25
15	Intensive induction/consolidation therapy without maintenance in adult acute lymphoblastic leukaemia: a pilot assessment British Journal of Haematology ·Martin Wernli, André Tichelli, V von Fliedner, G. Brun del Re, B. Chaputs, Martin F. Fey, M. Fopp, J Gmür, J‐P. Grob, E Jacky, A Pedrazzini, L. Schmid, H‐J. Senn, A Tobler, Aloïs Gratwohl	1994	14
16	False-Positive Human Serum Chorionic Gonadotropin in a Patient with a History of Germ Cell Cancer Oncology ·Andreas Trojan, Helen I. Joller‐Jemelka, Rolf A. Stahel, E Jacky, Martin Hersberger	2004	9
17	Risk-Adapted Chemotherapy of Germ Cell Tumors with Carboplatin, Etoposide and Bleomycin for Low-Risk and Cisplatin, Etoposide and Ifosfamide for High-Risk Patients Oncology ·Gregor Tscherry, E Jacky, L.M. Jost, Rolf A. Stahel	2000	7
18	Paraneoplastic hyperthyroidism: Figure 1 BMJ Case Reports ·Stefanie Köhler, Oliver Tschopp, E Jacky, Christoph Schmid	2011	6
19	Successful reintroduction of methotrexate after acute pneumonitis in a patient with acute lymphoblastic leukemia Annals of Hematology ·Tobias Fehr, E Jacky, EB Bächli	2003	5
20	Chloroma in Acute Myelogenous Leukemia New England Journal of Medicine ·C. Sauter, E Jacky	1998	5

About E Jacky

E Jacky is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Reproductive Medicine, having authored 25 papers that have together received 1.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (5 papers), Hematopoietic Stem Cell Transplantation (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Multiple Myeloma Research and Treatments (3 papers), Neutropenia and Cancer Infections (3 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Hematology (882 citations), Genetics (173 citations), Public Health, Environmental and Occupational Health (370 citations), Oncology (314 citations) and Pathology and Forensic Medicine (156 citations). E Jacky has collaborated with scholars based in Switzerland, Netherlands and Belgium. Frequent co-authors include Bob Löwenberg, Leo F. Verdonck, Peter C. Huijgens, Wim L.J. van Putten, Edo Vellenga, Martin F. Fey, Marc Boogaerts, Georgine E. de Greef, Gert J. Ossenkoppele and Gregor Verhoef. Their work appears in journals such as Annals of Oncology, British Journal of Haematology, Blood, Journal of Clinical Oncology and Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact